At a glance
- HCG, or human chorionic gonadotropin, is a large glycoprotein hormone that activates the luteinizing-hormone/chorionic-gonadotropin receptor. It is used in reproductive-endocrine research and is structurally more complex than a short synthetic peptide.
- Regulated HCG drug products exist for defined fertility and endocrine indications. This research vial is not one of those medicines, and labelled mass does not establish receptor potency, glycoform profile, sterility, or pharmaceutical equivalence.
- Measure LH/CG-receptor response and cyclic AMP in a validated receptor-positive model.
- Compare HCG with LH only when molar potency, glycosylation, and exposure duration are accounted for.
What HCG is—and what the name does not establish
HCG, or human chorionic gonadotropin, is a large glycoprotein hormone that activates the luteinizing-hormone/chorionic-gonadotropin receptor. It is used in reproductive-endocrine research and is structurally more complex than a short synthetic peptide.
HCG mimics the receptor activity of luteinizing hormone, producing cyclic-AMP-dependent signalling in responsive gonadal cells. Its longer persistence is influenced by the beta subunit and glycosylation pattern.
Questions to settle before interpreting a result
A useful HCG study begins with material identity, a defined model, a relevant comparator, and an endpoint chosen before the result is known. Broad catalogue language cannot replace those controls.
- Measure LH/CG-receptor response and cyclic AMP in a validated receptor-positive model.
- Compare HCG with LH only when molar potency, glycosylation, and exposure duration are accounted for.
- Verify biological activity as well as identity because glycoprotein-hormone mass alone can misstate functional dose.
How to read the HCG evidence
These evidence snapshots summarize the most important distinctions in the published record. They do not combine unlike models or turn an experimental signal into a human-use claim.
Established pathway
- Design
- LH/CG-receptor biology is clinically validated
- Finding
- Approved HCG products and reproductive physiology provide strong human evidence for the receptor pathway. That evidence remains product-, dose-, and indication-specific.
- Read with care
- This is an interpretation boundary, not a claim that a specific outcome has been established in people.
Biologic complexity
- Design
- Glycosylation helps determine activity and persistence
- Finding
- Two HCG preparations can share an amino-acid sequence but differ in glycoforms, bioactivity, aggregation, and assay response. Functional testing is therefore central to comparability.
- Read with care
- This is an interpretation boundary, not a claim that a specific outcome has been established in people.
Best comparison
- Design
- HCG resembles LH activity but is not identical to LH
- Finding
- Both engage the LH/CG receptor, while glycosylation and molecular structure alter persistence and assay behaviour. Matched mass alone is not a fair comparison.
- Read with care
- This is an interpretation boundary, not a claim that a specific outcome has been established in people.
What the evidence does not establish
Regulated HCG drug products exist for defined fertility and endocrine indications. This research vial is not one of those medicines, and labelled mass does not establish receptor potency, glycoform profile, sterility, or pharmaceutical equivalence.
Mechanism, cell, animal, observational, and controlled human evidence answer different questions. A positive result at one level cannot be silently promoted to another, and evidence for a sponsor’s defined product does not establish equivalence for an independently sourced research material.
Keep the publication and the vial separate
A published paper identifies its own sequence or chemical identity, formulation, manufacturing context, analytical controls, exposure, and test system. Matching a familiar name on a label is not enough to show that a catalogue vial is the same study material.
For practical research planning, verify the lot-specific identity and documentation, then write the model, comparator, endpoint, and stopping criteria before testing. This guide does not provide preparation, dosing, injection, or human-use instructions.
Sources
Links lead to the paper, official registry, regulator page, or product label used for this guide. Registry records describe protocols and status; they are not treated as positive results.
- Chorionic Gonadotropin official prescribing informationDailyMed · U.S. National Library of Medicine · Current label
Official label for a defined HCG product. Its biological potency, glycosylation, indications, and controls do not establish equivalence for an independently sourced material.
- Think twice before injecting peptides bought online: unauthorized products can seriously harm youHealth Canada · 2026
Official Canadian advisory explaining that a research-use label does not establish authorization, safety, efficacy, or product quality for human use.
Vote for HCG
This compound is not currently stocked. Add it to your five-choice catalogue ballot.